SRC and acute myeloid leukemia: To further illustrate these interactions, Figure 3 presents the docking conformations of three representative YWLS compounds—Isorhamnetin, Genkwanin, and Quercetin—with SRC, a non-receptor tyrosine kinase implicated in AML cell proliferation and survival.